Dr. Öğr. Üyesi Orçun Can

Makaleler

• How reliable is the high-volume definition in prostate cancer patients: the potential game-changing role of PSMA , 2023
• Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium , 2023
• Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database , 2021
• The effects of fulvestrant treatment on hormone receptor-positive metastatic breast cancer , 2020
• Metastatik Pankreas Kanserli Hastalarda FOLFİRİNOX Rejiminin Etkinlik ve Tolerabilitesi , 2018
• Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study , 2022
• Triglyceride Response to Oral Glucose Load: Is it Exaggerated in Metabolic Syndrome? , 2016
• Adrenocortical Carcinoma: Single Center Experience , 2020
• Non-urothelial Bladder Cancers: Single Center Experience , 2019
• Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study , 2021
• The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors , 2022
• Efect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study , 2022
• Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors , 2019
• Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study , 2020
• Serum fetuin-A and RANKL levels in patients with early stage breast cancer , 2023
• The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer , 2020
• The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study , 2022
• Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer , 2021
• External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database , 2023
• Prognostic significance of primary tumor localization in stage II and III colon cancer , 2018
• Factors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience , 2018
• Arrhythmogenic Right Ventricular Cardiomyopathy in a Patient Wıth Von Hippel Lindau Disease , 2021
• Küçük Hücreli Akciğer Kanserinde İmmünoterapi , 2023
• Mirror aneurysm of ICA terminus associated with adult polycystic kidney disease , 2021